CVS Health Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
CVS Health (CVS) PT Raised to $90 at RBC Capital
August 9, 2018 8:21 AM EDTRBC Capital raised its price target on CVS Health (NYSE: CVS) to $90.00 (from $84.00) while maintaining an Outperform rating.
Analyst George Hill views the updates on the Aetna transaction, PBM rebate retention, and the potential impact of regulatory changes positively and largely in-line with our positive view.
... MoreCVS Health (CVS) Tops Q2 EPS by 8c
August 8, 2018 6:57 AM EDTCVS Health (NYSE: CVS) reported Q2 EPS of $1.69, $0.08 better than the analyst estimate of $1.61. Revenue for the quarter came in at $46.7 billion versus the consensus estimate of $46.34 billion.
Same store sales increased 5.9% and pharmacy same store sales increased 8.3% in the three months ended... More
